Institutions / Carlyle Group Inc.
Carlyle Group Inc.
CIK 1527166 · Institutionalso an insider · as of Jun 30, 2026carlyle.com ↗
Portfolio value
$10.00B
Positions
19
As of
Jun 30, 2026
Portfolio trend
Portfolio value
$10.00B-26.3%Positions
19-5.0%Top holdings
Jun 30, 2026
| Company | Value | % of portfolio |
|---|---|---|
| Medline Inc. | $7.38B | 73.8% |
| StandardAero, Inc.SARO | $2.53B | 25.3% |
| Phathom Pharmaceuticals, Inc.PHAT | $37.94M | 0.4% |
| Invitation Homes Inc. | $20.03M | 0.2% |
| Pony AI Inc.PONY | $16.42M | 0.2% |
| Getty Images Holdings, Inc.GETY | $5.36M | 0.1% |
| Spruce Biosciences, Inc.SPRB | $2.09M | 0.0% |
| SunPower Inc.SPWR | $1.61M | 0.0% |
| Adicet Bio, Inc. | $1.59M | 0.0% |
| Forward Air CorpFWRD | $1.45M | 0.0% |
| OnKure Therapeutics, Inc. | $1.23M | 0.0% |
| Krispy Kreme, Inc.DNUT | $1.20M | 0.0% |
| Q32 Bio Inc. | $769.0K | 0.0% |
| Riley Exploration Permian, Inc.REPX | $530.4K | 0.0% |
| Nebius Group N.V. | $509.8K | 0.0% |
| Robinhood Markets, Inc. | $474.6K | 0.0% |
| Jasper Therapeutics IncJSPR | $448.9K | 0.0% |
| N-able, Inc. | $344.0K | 0.0% |
| Ramaco Resources, Inc.METC | $287.7K | 0.0% |
Activity
Jun 30, 2026View full history →
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2026 as of | Trim | SARO StandardAero, Inc. Common Stock | $-2.04B | -68.1M -44.60% | 84,587,035 25.30% of portfolio | high |
| Q2 2026 as of | Trim | Medline Inc. | $-1.11B | -28.2M -13.11% | 187,083,713 73.78% of portfolio | high |
| Q2 2026 as of | Trim | Q32 Bio Inc. | $-13.28M | -1.0M -94.53% | 60,363 <0.01% of portfolio | medium |
| Q2 2026 as of | Exit | Cubesmart | $-7.95M | -221K -100.00% | — | medium |
| Q2 2026 as of | Add | SPWR SunPower Inc. Common Stock | $1.31M | +1.9M +441.08% | 2,343,750 0.02% of portfolio | low |
| Q2 2026 as of | New | REPX Riley Exploration Permian, Inc. Common Stock | $530.4K | +16K | 16,092 <0.01% of portfolio | low |
| Q2 2026 as of | New | Nebius Group N.V. | $509.8K | +2K | 1,846 <0.01% of portfolio | low |
| Q2 2026 as of | Exit | NCNA NuCana plc ADR | $-480.0K | -133K -100.00% | — | low |
| Q2 2026 as of | Exit | Spyre Therapeutics, Inc. | $-315.1K | -10K -100.00% | — | low |
| Q2 2026 as of | Exit | XCUR Exicure, Inc. Common Stock | $-304.7K | -56K -100.00% | — | low |
Insider transactions
Also files Forms 3 / 4 / 5
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 29, 2026 | Sell | SARO StandardAero, Inc. Common Stock | $1.50B | -48.2M -31.60% | 104,427,303 31.56% of shares | high |
| Mar 10, 2026 | Sell | MDLN Medline Inc. Class A Common Stock | $1.07B | -26.1M -16.99% | 127,567,724 9.70% of shares | high |
| Feb 26, 2026 | Sell | SARO StandardAero, Inc. Common Stock | $624.17M | -19.8M -19.00% | 84,587,035 25.56% of shares | high |
| Mar 10, 2026 | Other | MDLN Medline Inc. Class A Common Stock | — | -2.1M -1.66% | 125,454,241 9.54% of shares | low |
| Mar 5, 2026 | Other | MDLN Medline Inc. Common Units of Medline Holdings, LP | — | -1.2M -1.93% | 61,629,472 4.69% of shares | low |
| Mar 4, 2026 | Other | MDLN Medline Inc. Common Units of Medline Holdings, LP | — | -8.1M -11.40% | 62,842,239 4.78% of shares | low |
| Mar 5, 2026 | Other | MDLN Medline Inc. Class B Common Stock | — | -1.2M -1.93% | 61,629,472 4.69% of shares | low |
| Mar 5, 2026 | Other | MDLN Medline Inc. Class A Common Stock | — | +1.2M +0.80% | 153,673,564 11.69% of shares | low |
| Mar 4, 2026 | Other | MDLN Medline Inc. Class B Common Stock | — | -8.1M -11.40% | 62,842,239 4.78% of shares | low |
| Mar 4, 2026 | Other | MDLN Medline Inc. Class A Common Stock | — | +8.1M +5.60% | 152,460,797 11.60% of shares | low |